Table 3.

Treatment and covariate effects on unfavourable outcome for women (N = 426)

	r/n	OR (unadjusted), 95% CI	p	aOR (adjusted), 95% CI	p
Treatment
HRZE	10/138
2MHRZ/2MHR	11/149	0.98 (0.40–2.43)	0.973	–	–
2EMRZ/2MR	18/139	1.93 (0.84–4.39)	0.119
Age
≤ 30 years	20/223	1.0		–	–
> 30 years	19/203	0.95 (0.48–1.88)	0.881
BMI
< 18.5	19/189	1.0		–	–
≥ 18.5	20/237	1.03 (0.51–2.12)	0.926
Race
Asian	15/135	1.0
Black	9/163	0.39 (0.14–1.08)	0.070	–	–
Mixed race and Caucasian	15/128	0.45 (0.14–1.45)	0.182
Smoking
Never smoked	21/292	1.0		1.0
Ever smoked	18/134	2.69 (0.92–7.90)	0.071	2.00 (1.03–3.90)	0.041
HIV
Negative	36/385	1.0		–	–
Positive	3/41	1.16 (0.28–4.84)	0.835
Cavities
No cavities	9/110	1.0		–	–
Cavities	30/316	1.16 (0.51–2.63)	0.715